Siemens Healthcare Ltd. (South Korea)

Siemens Healthineers Co., Ltd. is a Korean subsidiary of Siemens Healthineers, headquartered in Erlangen, Germany. The company was spun off from SIEMENS AG in 2016 and went public in 2018. With approximately 1,1 employees, Siemens Healthineers focuses on research and development to improve human health and the quality of life for patients and medical staff. The company provides solutions in imaging diagnosis, advanced treatment, and diagnostic tests to accurately diagnose and prevent diseases and provide optimal treatment. They have expanded their presence in the medical field through mergers and acquisitions, including Verion, a global leader in the cancer treatment sector. Siemens Healthineers is at the forefront of healthcare innovation, with strengths in digital, data, and AI, as well as patient twining. They are committed to treating threatening diseases such as cancer, cardiovascular, and neurological diseases, aiming to deliver the best outcomes for medical staff and patients. In the ultrasound business, Siemens Healthineers has two R&D centers and production plants in Seongnam and Pohang, making them unique in the domestic medical device field. They have also achieved significant export success, winning the $2 million export tower. The company promotes a corporate culture that respects Diversity & Inclusion and values the power and potential of each employee. They also demonstrate ethical responsibility as a healthcare company by contributing to the development of the Korean medical industry through various social contribution activities, such as health checkup services for children with medical blind spots, blood donation for employees, and donation of goods to create jobs for people with disabilities. Siemens Healthineers is committed to conducting ethical and responsible management as a healthcare company and aims to be a reliable partner for domestic medical staff and patients in the future.